YD Bio (YDES) Non-Current Assets (2024 - 2026)
YD Bio's (YDES) quarterly Non-Current Assets came in at $4.5 million in Q2 2026, up 0.55% year-over-year from $4.4 million in Q2 2025, and up 8.75% quarter-over-quarter from $4.1 million in Q4 2025.
Powered by 
Analysis
YD Bio (YDES) Non-Current Assets (2024 - 2026) Analysis & Trends
YD Bio (YDES) has reported Non-Current Assets for 3 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 0.55% year-over-year to $4.5 million in Q2 2026; TTM through Jun 2026 was $16.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.1 million, up 20.99% from the prior year.
- Non-Current Assets was $4.5 million for Q2 2026 at YD Bio, up from $4.1 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $4.5 million in Q2 2026 and troughed at $3.4 million in Q4 2024.
- A 3-year average of $4.1 million and a median of $4.3 million in 2025 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets advanced 20.99% in 2025 and advanced 0.55% in 2026, its largest moves.
- Over 3 years, Non-Current Assets stood at $3.4 million in 2024, then increased by 20.99% to $4.1 million in 2025, then gained by 8.75% to $4.5 million in 2026.
- The last three Non-Current Assets figures came in at $4.5 million (Q2 2026), $4.1 million (Q4 2025), and $4.4 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 60.68 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 35.42 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 14.88 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 23.28 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 5.15 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 1.96 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 24.78 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 564.41 Mn |
| 10 | YD Bio | 225.82 Mn | 223.16 Mn | - | 4.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.47 Mn |
| Dec 31, 2025 | 4.11 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Dec 31, 2024 | 3.40 Mn |
API Access
YD Bio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=YDES&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "YDES", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=YDES&period=max&api_key=YOUR_API_KEY");
const data = await res.json();